Ono Pharmaceutical Co., Ltd. provided earnings guidance for the year ending March 31, 2017. For the year ending March 31, 2017, the company expects revenue to be JPY 259 billion, operating profit to be JPY 72.5 billion and profit before tax to be JPY 75 billion. For the year ending March 31, 2017, the company expects profit attributable to owners of parent to be JPY 55.8 billion, or JPY 105.28 per basic share.